STOCK TITAN

Eli Lilly (LLY) EVP Patrik Jonsson awarded 4,818 shares in Form 4

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Eli Lilly executive Patrik Jonsson, EVP & President, LLY International, reported an acquisition of company stock through an equity award. On 02/09/2026 he received 4,818.052 shares of common stock at $1,044.67 per share, bringing his directly held stake to 60,646.62 shares, with additional indirect holdings in a 401(k) plan.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jonsson Patrik

(Last) (First) (Middle)
LILLY CORPORATE CENTER

(Street)
INDIANAPOLIS IN 46285

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & President, LLY Int'l
3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/09/2026 A 4,818.052 A $1,044.67 60,646.62 D
Common Stock 611.2 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Jonathan Groff for Patrik Jonsson, pursuant to authorization on file 02/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Eli Lilly (LLY) report for Patrik Jonsson?

Eli Lilly reported that EVP & President, LLY International, Patrik Jonsson acquired 4,818.052 shares of common stock on February 9, 2026. The acquisition was coded as a grant or award, rather than an open-market purchase or sale, and increased his direct share ownership.

How many Eli Lilly (LLY) shares does Patrik Jonsson own after this Form 4?

After the reported grant, Patrik Jonsson directly beneficially owns 60,646.62 shares of Eli Lilly common stock. The filing also notes 611.2 shares held indirectly in a 401(k) plan, reflecting additional indirect beneficial ownership separate from his primary direct holdings.

What was the price per share for the Eli Lilly (LLY) stock granted to Patrik Jonsson?

The grant to Patrik Jonsson was reported at a price of $1,044.67 per share for Eli Lilly common stock. This value is used for reporting purposes on the Form 4 and applies to the 4,818.052 shares acquired in the equity award transaction on February 9, 2026.

Was Patrik Jonsson’s Eli Lilly (LLY) transaction a purchase or a grant?

The transaction was reported with code A, described as a grant, award, or other acquisition. This indicates Jonsson received 4,818.052 Eli Lilly shares as part of compensation or a similar arrangement, not as an open-market cash purchase of common stock.

What positions does Patrik Jonsson hold at Eli Lilly (LLY)?

Patrik Jonsson is identified as an officer of Eli Lilly, serving as EVP & President, LLY International. This senior leadership role is disclosed on the Form 4, which reports his beneficial ownership changes and links the equity grant to his executive position with the company.

Does Patrik Jonsson have indirect Eli Lilly (LLY) share ownership?

Yes. In addition to his direct holdings, the Form 4 notes 611.2 Eli Lilly common shares held indirectly through a 401(k) plan. These are classified as indirect beneficial ownership, separate from the 60,646.62 shares he holds directly after the February 9, 2026 grant.
Lilly Eli & Co

NYSE:LLY

View LLY Stock Overview

LLY Rankings

LLY Latest News

LLY Latest SEC Filings

LLY Stock Data

806.39B
940.96M
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS